Results 191 to 200 of about 45,681 (215)

Evidence for a true post-β-lactamase-inhibitor effect of clavulanic acid against Klebsiella pneumoniae and Haemophilus influenzae

Clinical Microbiology and Infection, 2001
ObjectiveThe purpose of this study was to investigate and characterize in vitro the post-β-lactamase inhibitor effect (PLIE) of clavulanic acid against two β-lactamase-producing species of bacteria.MethodsThe PLIE was investigated against one strain of ...
H Monteil
exaly   +2 more sources

Some of the next articles are maybe not open access.

Related searches:

Durlobactam, a Broad-Spectrum Serine β-lactamase Inhibitor, Restores Sulbactam Activity AgainstAcinetobacterSpecies

Clinical Infectious Diseases, 2023
KRISZTINA M Papp-Wallace, Sarah M Mcleod, Alita A Miller   +2 more
exaly  

New β-Lactam–β-Lactamase Inhibitor Combinations

Clinical Microbiology Reviews, 2020
Dafna Yahav, , Leonard Leibovici
exaly  

In vitro comparative activity of the new beta-lactamase inhibitor taniborbactam with cefepime or meropenem against Klebsiella pneumoniae and cefepime against Pseudomonas aeruginosa metallo-beta-lactamase-producing clinical isolates

International Journal of Antimicrobial Agents, 2021
Joseph Meletiadis, Paschalis Paranos, Panagiota-Christina Georgiou   +2 more
exaly